• 1
    Sospedra, M.andMartin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683747.
  • 2
    Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. and Sallusto, F., Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007. 8: 942949.
  • 3
    Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, al.,Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007. 8: 950957.
  • 4
    Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K. et al., IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008. 454: 350352.
  • 5
    Amadi-Obi, A., Yu, C. R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I. et al., T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 2007. 13: 711718.
  • 6
    Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 18491861.
  • 7
    Manel, N., Unutmaz, D. and Littman, D. R., The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008. 9: 641649.
  • 8
    Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L. and Aloisi, F., Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 2006. 65: 124141.
  • 9
    Bailey, S. L., Schreiner, B., McMahon, E. J. and Miller, S. D., CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007. 8: 172180.
  • 10
    Huang, Y. M., Xiao, B. G., Ozenci, V., Kouwenhoven, M., Teleshova, N., Fredrikson, S.and Link, H., Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 1999. 99: 8290.
  • 11
    Zhang, X., Jin, J., Tang, Y., Speer, D., Sujkowska, D.and Markovic-Plese, S., IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J. Immunol. 2009. 182: 39283936.
  • 12
    Vieira, P. L., Heystek, H. C., Wormmeester, J., Wierenga, E. A.and Kapsenberg, M. L., Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 2003. 170: 44834488.
  • 13
    Kwak, B., Mulhaupt, F., Myit, S. and Mach, F., Statins as a newly recognized type of immunomodulator. Nat. Med. 2000. 6: 13991402.
  • 14
    Yilmaz, A., Reiss, C., Tantawi, O., Weng, A., Stumpf, C., Raaz, D., Ludwig, J. et al., HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 2004. 172: 8593.
  • 15
    Peng, X., Jin, J., Giri, S., Montes, M., Sujkowski, D., Tang, Y., Smrtka, al., Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. J. Neuroimmunol. 2006. 178: 130139.
  • 16
    Kobayashi, M., Azuma, E., Ido, M., Hirayama, M., Jiang, Q., Iwamoto, S., Kumamoto, T. et al., A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J. Immunol. 2001. 167: 35853591.
  • 17
    Shurin, G. V., Tourkova, I. L., Chatta, G. S., Schmidt, G., Wei, S., Djeu, J. Y.and Shurin, M. R., Small rho GTPases regulate antigen presentation in dendritic cells. J. Immunol. 2005. 174: 33943400.
  • 18
    Markovic-Plese, S., Singh, A. K. and Singh, I., Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair. Future Neurol. 2008. 3: 153167.
  • 19
    Cantrell, D. A., GTPases and T-cell activation. Immunol. Rev. 2003. 192: 122130.
  • 20
    Greenwood, J., Steinman, L. and Zamvil, S. S., Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat. Rev. Immunol. 2006. 6: 358370.
  • 21
    Li, X., Liu, L., Tupper, J. C., Bannerman, D. D., Winn, R. K., Sebti, S. M., Hamilton, A. D. et al., Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J. Biol. Chem. 2002. 277: 1530915316.
  • 22
    Liao, J. K., Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 2002. 110: 285288.
  • 23
    Yilmaz, A., Reiss, C., Weng, A., Cicha, I., Stumpf, C., Steinkasserer, A., Daniel, W. G. et al., Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J. Leukoc. Biol. 2006. 79: 529538.
  • 24
    Becker, C. E., Creagh, E. M. and O'Neill, L. A., Rab39a binds caspase-1 and is required for caspase-1-dependent interleukin-1beta secretion. J. Biol. Chem. 2009. 284: 3453134537.
  • 25
    Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J. et al., Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 2004. 363: 16071608.
  • 26
    Zhang, X., Jin, J., Peng, X., Ramgolam, V. S. and Markovic-Plese, S., Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORc in CD4+ lymphocytes. J. Immunol. 2008. 180: 69886996.
  • 27
    Li, Y., Chu, N., Rostami, A. and Zhang, G. X., Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J. Immunol. 2006. 177: 16791688.
  • 28
    Zhou, L., Ivanov, II, Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E. et al., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007. 8: 967974.
  • 29
    Simon, A. R., Vikis, H. G., Stewart, S., Fanburg, B. L., Cochran, B. H. and Guan, K. L., Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000. 290: 144147.
  • 30
    Pelletier, S., Duhamel, F., Coulombe, P., Popoff, M. R.and Meloche, S., Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol. Cell. Biol. 2003. 23: 13161333.
  • 31
    Chen, Z., Tato, C. M., Muul, L., Laurence, A. and O'Shea, J. J., Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis. Rheum. 2007. 56: 29362946.
  • 32
    Ramgolam, V. S. and Markovic-Plese, S., Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis. J. Signal Transduct. 2011. 2011: 635721.
  • 33
    Kubo, M., Hanada, T. and Yoshimura, A., Suppressors of cytokine signaling and immunity. Nat. Immunol. 2003. 4: 11691176.
  • 34
    Samavati, L., Rastogi, R., Du, W., Huttemann, M., Fite, A. and Franchi, L., STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol. Immunol. 2009. 46: 18671877.
  • 35
    Wong, P. K., Egan, P. J., Croker, B. A., O'Donnell, K., Sims, N. A., Drake, S., Kiu, H. et al., SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 2006. 116: 15711581.
  • 36
    Zhang, X., Tao, Y., Troiani, L. and Markovic-Plese, S., Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis. J. Immunol. 2011. 187: 34313437
  • 37
    Ghittoni, R., Napolitani, G., Benati, D., Ulivieri, C., Patrussi, L., Laghi Pasini, F., Lanzavecchia, A. et al., Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. Eur. J. Immunol. 2006. 36: 28852893.
  • 38
    Takai, Y., Sasaki, T. and Matozaki, T., Small GTP-binding proteins. Physiol. Rev. 2001. 81: 153208.
  • 39
    Zamvil, S. S. and Steinman, L., Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS. Neurology. 2002. 59: 970971.
  • 40
    McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F. et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001. 50: 121127.